Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. - Wikidata - wikimedia - TriplyDB

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

http://www.wikidata.org/entity/Q39866377

about

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA Human T cell responses to Japanese encephalitis virus in health and disease Status of hepatitis C virus vaccination: Recent update Immune and non-immune responses to hepatitis C virus infection Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?State-of-the-art human gene therapy: part I. Gene delivery technologies Immune responses to HCV and other hepatitis viruses T cell responses in hepatitis C virus infection: historical overview and goals for future research A global approach to HIV-1 vaccine development Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice Supplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini Review State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization Hepatitis C.Engineering New Approaches to Cancer Vaccines IL-33 induces nuocytes and modulates liver injury in viral hepatitis.The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus Advanced molecular surveillance of hepatitis C virus Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.Human parvovirus 4 'PARV4' remains elusive despite a decade of study Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.Adenoviral vectors as novel vaccines for influenza.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Protection of non-human primates against rabies with an adenovirus recombinant vaccine.CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.Protective immunity against hepatitis C: many shades of gray.Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Hepatitis C virus hypervariable region 1 variants presented on hepatitis B virus capsid-like particles induce cross-neutralizing antibodies.Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.

P2860

Q24289279-AEAABD05-12AD-44FA-B718-64750575EB91 Q24289630-3442E97E-2219-4561-844D-2829206C4A26 Q26774612-11A0A2EC-227F-4432-9DE1-99EABA2EFEF2 Q26782040-467EEED0-F509-4CDF-B65A-4DB82A5A05C9 Q26782083-8EEA2F25-A1B2-4098-BA2C-6103BE94AF5B Q26783884-594B7941-F980-4B03-ACDC-8CAE93C10F1A Q26799141-F1504939-E3F4-4A0A-B22C-246B077E44CC Q26825575-DAE70F82-1F46-452F-A908-9CE60C3440A2 Q26866955-39F4E94E-12D4-4707-9FB5-585AB44821BF Q27003510-535DF53D-BEF7-4E49-AFD4-020659D170D7 Q27024614-7C67C567-C4BA-4349-8389-FD7E720C8308 Q27303766-DE9767EC-E905-492E-AC75-6E7936AF3067 Q28068362-E8AE7BDA-8521-4A2D-BBBD-D97AA7E13F82 Q28079102-1C26F20D-8090-4C24-B02B-092C94F31BCB Q28084654-CD555A1B-A95A-4FE3-8B50-2E6D84512A74 Q28085563-A710BF5A-8887-470C-9FF8-BD6887632112 Q28588039-09FFC46D-470A-4988-8AC9-51AE7485165F Q28602408-52B9D3D9-ECA5-4CDD-BECC-B2187B38AEE8 Q28604286-33FA6773-52D2-4953-AB75-CC138D487C0F Q28650908-48114E11-BE0E-41FC-931E-CFEAD380966B Q28706340-7F5BB7BD-9950-4036-91DA-11CFEE9EBCA5 Q30208996-59D02F0D-323B-44A0-915E-4FE9FD3AD309 Q30223906-A4967A83-03A4-416E-8861-752921917DAB Q30238496-53D25E0C-353E-4C6F-8AE4-A8959B55D83F Q30300575-A5873FCC-66D9-4757-A5CA-9C43BD2B496D Q30370445-D3BCA6BC-6407-4E1B-ACD3-17C8AB771C82 Q30374314-255BDE1B-9957-4EA1-B0F8-713F0F34EBAB Q33586992-0F209047-660F-4771-A9F1-1565C7C7EC6B Q33601808-13119EE6-D449-4DB0-8320-45850559D9E4 Q33602744-310332A8-047C-44BE-AA48-87FF2508A6EA Q33630150-F7160981-C9F9-4E42-B3ED-7444AF30F76F Q33684288-D403BD8B-91DC-4DDC-8233-8FE8EF4B0713 Q33718778-2CCAF176-1AB4-4C67-82A1-E464FE188EF8 Q33724960-7DC30F27-6AC7-4CCB-81DF-4C06E7CA25FC Q33743457-B0B4BEA5-C997-4101-B09A-88884C0BF7E2 Q33759224-5DBFCE9B-682B-477A-A196-2AD38E72D9DC Q33826033-AC7FB812-79F5-40BC-894C-74DD924C48FF Q33868760-E0694840-A12B-4593-91FC-A7AE02E95D2E Q33890011-6E764E25-CA7E-4AB9-9652-DF5D238C22CC Q34028154-19069996-0E45-45EE-9FDF-508B5E09B11A

P2860

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

http://www.wikidata.org/entity/Q39866377

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@en

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@nl

type

label

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@en

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@nl

prefLabel

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@en

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@nl

P1433

Q39866377-02853191-2BFB-4413-992D-B2F6B172EAC0

P1476

Q39866377-94F9AEC3-11C3-4907-B64E-F4D9619D6A31

P2093

Q39866377-07F7B913-99EC-4C56-BBED-AA76CA028CC9

Q39866377-11C900A3-2F1E-4CE9-9FD3-DE4A6CFE9DAB

Q39866377-2529117D-AC2F-4B4B-BD1A-B5356ADB2775

Q39866377-26E3A35E-D149-4B97-A377-0A799DC0D9BA

Q39866377-3ED3D427-7582-436A-9382-D071A2939063

Q39866377-611DEEC4-FAA8-46D0-AE37-08AFB9E2E987

Q39866377-641A5023-E4FA-4546-A4FD-2A26C02A75C2

Q39866377-8C5253AB-75A4-4C8B-8638-C1FE1CBA8419

Q39866377-8D002FC0-1D33-4123-A6FB-D7F411C31664

Q39866377-9F511C97-B6E4-42A7-AFD0-E0B78422CD92

P2860

Q39866377-037ADE78-BFDA-491E-A737-D90B598B8361

Q39866377-111E8DE6-0C09-4215-91EA-66CE45B5FE2E

Q39866377-11514595-9184-410F-B72C-A9F2AC188840

Q39866377-122B94AD-574E-41A2-8CA2-9F7CCBFF915B

Q39866377-16285739-63D8-4B7C-B7FE-FDB5122D73EB

Q39866377-1BB859E3-0C71-4137-B6ED-D785DBE7BD89

Q39866377-26A0AEFC-8DC2-454B-BCE3-D85DB910FB5A

Q39866377-2EAB5542-D452-4BD7-8F22-23D0551A6251

Q39866377-3145D6FF-DF78-4577-B3D3-49CF2F702E9D

Q39866377-42E3904A-0B5A-4698-A067-445BD8FD92B1

P304

Q39866377-8D4C8BBD-C9A2-4C6A-9462-8A34E8F2BCDC

P31

Q39866377-CC0967CA-7941-4EFA-9C75-CDA85D2EEF58

P356

Q39866377-F3FC5DE2-1FE7-491E-833B-3E547B74738C

P407

Q39866377-65003D2A-227E-446F-9760-77EEC38783CC

P433

Q39866377-62417333-D9EE-4BE3-AAD3-FCD777141A0E

P478

Q39866377-84190E0A-A090-4265-AEF5-DD3E22D3D95F

P50

Q39866377-0977260A-7AD4-4BF9-B725-9396E69D5406

Q39866377-4534C34C-67D1-4CBD-ADA1-5A89F7B914C2

Q39866377-652F5761-099E-4836-B304-E681B9444953

Q39866377-7D9EAFEF-ADD4-4A64-A918-13899A3EC0BF

Q39866377-D93BDE5A-5A00-417A-853F-A721A02C2691

P577

Q39866377-0A335090-E6B7-4526-A59A-4788B49627A5

P5875

Q39866377-AFFD3F44-76E7-4452-AF1B-FF3F58A7E6F3

P698

Q39866377-E6283F9D-B93C-47B0-B406-320CE1187D98

P921

Q39866377-5604F69A-31E9-4FB2-B901-6439CD89FE9E

P932

Q39866377-DC2416BE-79FE-4E80-9356-5623A38C5FF3

P356

SCITRANSLMED.3003155

P1433

Science Translational Medicine

P1476

Novel adenovirus-based vaccine ...... cell responses to HCV in man.

@en

P2093

Abby Harrison

http://www.w3.org/2001/XMLSchema#string

Adrian Hill

http://www.w3.org/2001/XMLSchema#string

Alfredo Nicosia

http://www.w3.org/2001/XMLSchema#string

Anthony Brown

http://www.w3.org/2001/XMLSchema#string

Antonella Folgori

http://www.w3.org/2001/XMLSchema#string

Ayako Kurioka

http://www.w3.org/2001/XMLSchema#string

Chris Willberg

http://www.w3.org/2001/XMLSchema#string

Cinzia Traboni

http://www.w3.org/2001/XMLSchema#string

David Adams

http://www.w3.org/2001/XMLSchema#string

Eleanor Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

Analysis of successful immune responses in persons infected with hepatitis C virus

Hepatitis C virus infection

Determinants of viral clearance and persistence during acute hepatitis C virus infection

Restoring function in exhausted CD8 T cells during chronic viral infection

P304

115ra1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3003155

http://www.w3.org/2001/XMLSchema#string

P407

P433

115

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Stefania Capone

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51983407

http://www.w3.org/2001/XMLSchema#string

P698

22218690

http://www.w3.org/2001/XMLSchema#string

P921

P932

3627207

http://www.w3.org/2001/XMLSchema#string